REG - Polar Cap Glb Health PCGH ZDP PLC - AGM Presentation

Polar Capital Global Healthcare TrustAnnouncement

12/02/2026 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260212:nRSL8330Sa&default-theme=true

RNS Number : 8330S  Polar Capital Global Health Tst PLC  12 February 2026

Polar Capital Global Healthcare Trust plc ("the Company")

 

Legal Entity Identifier: 549300YV7J2TWLE7PV84

 

 

 

12 February 2026

 

 

AGM Presentation

 

As previously reported in the Company's Annual Report and Accounts for the
year ended 30 September 2025, the Investment Manager's pre-recorded audio
presentation has been uploaded to the Company's website ahead of the Annual
General Meeting taking place at 2pm on 26 February 2026. The presentation can
be accessed through the link provided:

 

Healthcare: From out of favour to underestimated | Polar Capital Global
Healthcare Trust
(https://www.polarcapitalglobalhealthcaretrust.co.uk/News-Views/Post/18111/Healthcare_From_out_of_favour_to_underestimated/)

 

Further information on the formal business to be proposed at the AGM is
provided in the Notice of Annual General Meeting which is also available on
the Company's website. Shareholders are encouraged to send any questions they
may have ahead of the AGM to cosec@polarcapital.co.uk
(mailto:cosec@polarcapital.co.uk) stating the subject matter as PCGH-AGM. The
Company will endeavour to answer relevant questions at the meeting or on the
Company's website as appropriate.

 

To receive the latest monthly factsheet for the Company on an ongoing basis,
including the Investment Manager's commentary, please register here
(https://email.polarcapitalfunds.com/retail/preference/global-healthcare-trust.asp)
.

 

For further information, please contact:

 

T Lago FCG

Director

Polar Capital Secretarial Services

Corporate Secretary

Telephone Number: 020 7227 2700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBLGDDCDBDGLD



            Copyright 2019 Regulatory News Service, all rights reserved